JNJ-Super company, Super stock! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : JNJ-Super company, Super stock!

JNJ 161.17

-0.5%

Oct 2 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Sr K	9/16/2011 7:01:42 PM
	of 552

MANAGEMENT \| SEPTEMBER 16, 2011, 5:34 P.M. ET J&J Negotiated Over Executive's Departure By JOANN S. LUBLIN And JONATHAN D. ROCKOFF Johnson & Johnson's insistence on enforcing a non-compete agreement to keep senior executive Michael Mahoney from joining archrival Boston Scientific Corp. as chief executive led to unusual employment terms at the medical device maker, according to people familiar with the matter. J&J agreed to allow Mr. Mahoney to join Boston Scientific only after the company promised the 46-year-old won't supervise competing businesses or become its chief executive until late 2012 and agreed to have its general counsel personally monitor compliance, those people said. Boston Scientific said Tuesday that Mr. Mahoney, who had been heading J&J's medical devices and diagnostics group, would become its president next month and CEO effective on Nov. 1, 2012. In the interim, Hank Kucheman, who has been running Boston Scientific's defibrillator business, will serve as chief executive. Current CEO Ray Elliott is retiring. wsj.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next